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Objective: To evaluate the feasibility of hysteroscopic resection (HsR) for primary surgical
management of missed abortion. Reproductive outcomes and potential benefit of this
technique will be compared to traditional dilatation and curettage (D&C).
Design: Retrospective cohort study in two Departments (Gynecology and Obstetrics)
of a tertiary medical care center (Canadian Task Force classification II-2).
Patients: Women with first trimester missed abortion.
Intervention: Two techniques were used for the management of missed abortion:
ultrasound-guided dilatation and curettage (D&C) and hysteroscopic resection (HsR).
Results: We evaluated 358 patients who underwent primary surgical removal of
missed abortion. Hundred seventy three patients have been treated by D&C and 185
underwent HsR. In the HsR group, 110 patients (59.5%) have obtained their pregnancy
with in vitro fertilization (IVF) vs. 7 patients (4.0%) in the D&C group which make
the HsR population hypofertile in comparison to the D&C population. The intra- and
post-operative complication rates are low and comparable. Intrauterine anomalies were
diagnosed during the HsR in 10 patients (5.4%) and could be investigated after the
intervention as a possible cause of miscarriage. Because of the difference in term of
fertility, the reproductive outcomes have been analyzed by multivariate analysis. The
hazard ratio of pregnancy at 6 months, adjusted to the factor IVF for D&C compared
to HsR is 0.69 [0.49–0.96] (p = 0.026). That could represent a significant benefit in the
particular population followed in IVF, but regarding the retrospective analysis, and the
very different population in the two groups, it doesn’t allow us to draw any evidence
based conclusion.
Conclusion: Hysteroscopic resection is a feasible and safe procedure for the
management of missed abortion that could increase the diagnosis of uterine
abnormalities. With all the limitation of the design of our study, our data seems to show
a trend to a potential benefit in term of reproductive outcomes for hypofertile patient
undergoing IVF treatment.
Keywords: missed abortion, management, curettage, hysteroscopic resection, reproductive outcomes
de Codt et al. Hysteroscopic Resection for Missed Abortion
INTRODUCTION
Approximately 10–20% of first trimester pregnancies end up
in a miscarriage (1). In some cases, the product of conception
remains either in full (missed abortion) or in part (incomplete
miscarriage) in the uterine cavity and is called “Retained product
of conception” (2) (RPOC). They are classically managed using
three different methods: expectant care, drug-based management
and D&C. The patient generally considers the miscarriage
as a failure and usually wants to get pregnant as soon as
possible after this episode. Hence the frequency of this situation
and the importance of preserving fertility, the three methods
are frequently compared in the literature (1–3). The existing
literature suggests that D&C allows a better clearing of the
uterus when compared to the two other techniques (3) but it
induces more intrauterine adhesions (4) (IUAs). The medical
and expectant management sometimes require an emergency
curettage for uncontrolled bleeding or abdominal pain (2).
Despite these facts, the three methods show no difference in
terms of infections (2) and fertility (5).
Up to now, D&C is the method of choice for surgical
evacuation of residual trophoblastic tissue. Vacuum aspiration
should be preferred to sharp curettage as it causes less pain and
less blood loss (6). It is also complicated by fewer IUAs (7) which
still occur in about 15% (8) and compromise the fertility of the
patient. Some new opportunities have recently been developed
to improve the outcome of surgical management of miscarriage.
The ultrasound-guided curettage allows more accuracy in the
resection of trophoblastic tissue and endometrium than blind
D&C (9). The hysteroscopic resection (HsR) of RPOC is also
a new alternative to D&C. A few studies (9–11) have already
compared the two surgical techniques in case of post-operative
or post-partum trophoblastic remnants. To our knowledge,
there is no study comparing D&C to HsR in primary surgical
management of missed abortion.
MATERIALS AND METHODS
After approval of the “Comité d’Ethique Hospitalo-Facultaire”
(reference number: 2014/20MAI/254), we conducted a
retrospective analysis of all the patients presenting a missed
abortion managed by HsR between 2010 and 2014 in the
department of Surgical Gynecology, IVF and Andrology of
the Cliniques universitaires Saint-Luc, Brussels, Belgium. The
data’s from the operative report, early, and post-operative
complication and reproductive outcomes were collected.
In order to have a classical D&C arm to compare, we
also collected the data’s from the patients managed in the
department of Obstetrics of Cliniques universitaires Saint-Luc
that use systematically ultrasound guided D&C to manage
missed abortion.
The research was made using Medical Explorer R© software
and Diamm R©. Statistical analysis was performed using the
Kolmogorov-Smirnov test to evaluate the data normality.
Student and χ2 tests were used to study continuous and
categorical variables. We performed a success of pregnancy
analysis adjusted to the conception mode 6 months after the
procedure (spontaneous vs. assisted) with a multivariable
Cox regression model. p < 0.05 was considered statistically
significant. All analyses were performed using STATISTICA
software version 7 (Statsoft, Inc., 2004). This paper is
reported following the “STrengthening the Reporting
of OBservational studies in Epidemiology” (STROBE)
statement (12).
Operative Technique
- Ultrasound-guided curettage: the procedure is performed
under general anesthesia. The cervix is dilated to Hegar
no. 10 to allow introduction of a suction cannula. The
trophoblastic tissue is then removed by vacuum aspiration
with ultrasound guidance. Should significant bleeding occur,
10 IU of Syntocinon R© would be administered intravenously.
- Hysteroscopic resection: the procedure is conducted under
general anesthesia. The cervix is dilated to Hegar no.
10. Uterine distension is made by continuous glycine
flow. Hystero-resectoscope is introduced with the loop
to keep unstuck the trophoblastic sac by gentle motions
without application of current. A polyp forceps is then
inserted through the cervix to grab the free sac. Re-
introduction of the hysteroscope to verify the emptiness
of the uterus (supplemental video shows full length
procedure). The remaining level of glycine is controlled
at the end of the procedure to evaluate the resorption. Should
significant bleeding occur, 10 IU of Syntocinon R© would be
administered intravenously.
RESULTS
Between 2010 and 2014, 173 patients in the D&C group and 185
in the HsR group were, respectively, managed in the Obstetrics
and Surgical Gynecology, IVF and Andrology Departments
of our hospital for missed abortion. The patient’s data are
summarized in Table 1. Demographics for both groups were
similar in term of age and previous uterine surgery but the
two populations were different in term of fertility: 110 patients
(59.5%) in the HsR group has obtained their pregnancy by
in vitro fertilization (IVF) vs. 7 patients (4.0%) in the D&C
group. This difference was due to the general organization
of the hospital. IVF service is part of the Gynecologic
Department and then miscarriage after IVF are preferentially
addressed to the surgeon from this Department, performing
systematically HsR. The spontaneous miscarriage in the event
of known intra uterine pregnancy, not from the IVF service,
are systematically addressed to the Obstetrics Department. This
could also explain the significant difference in gravidity, parity,
gestational age at miscarriage, and drug based management
(IVF patients usually prefer expectant management as it is
easier psychologically than drug based management). Both
interventions were performed by gynecologists or senior interns
in gynecology. Intraoperative and post-operative complications
are low and comparable in both groups as shown in Table 2
with a slightly increased risk of hemorrhage in the D&C
group. There were no complication due to glycine resorption.
Intrauterine anomalies were diagnosed during the HsR in
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TABLE 1 | Characteristics of the patients undergoing either HsR or D&C for
missed abortion (n = 358).
Characteristics HsR (n = 185) D&C (n = 173) p-value
Age (years; mean ± SD) 34.1 ± 5.6 34.2 ± 5.2 0.360
Gravidity (n; mean ± SD) 2.4 ± 1.6 3.0 ± 1.9 <0.001
Parity (n; mean ± SD) 0.6 ± 1.0 1.1 ± 1.1 <0.001
Previous uterine surgery 60 (32.4%) 56 (32.4%) 1.000
Mode of pregnancy <0.001
IVF 110 (59.5%) 7 (4.0%)
Spontaneous 75 (40.5%) 166 (96.0%)
Gestational age at
miscarriage (week ± SD)
9.1 ± 2.3 9.9 ± 2.4 0.004
Time delay before surgery
(days ± SD)
11.3 ± 5.9 8.7 ± 5.6 0.004
Failure of prostaglandin
treatment
17 (9.2%) 122 (70.5%) <0.001
TABLE 2 | Surgical characteristics and complications following HsR and D&C for
missed abortion.
HsR (n = 185) D&C (n = 173) p-value
Intervention median time (min) 00:20 00:16 <0.001






Cervical tears 1 1 0.962
Perforation 1 0 0.33
Hemorrhage (>500cc) 0 4 0.037
Post-operative complication
Due to glycine resorption 0 ***
Endometritis 2 1 0.601
***Non applicable.
10 patients (5.4%) while this information is not available
in regard to the D&C technique. There was no systematic
control of the cavity after the procedure so we have no
information regarding the potential trophoblastic remnants and
IUA’s after surgery.
The post-operative fertility is presented in Table 3. Hundred
sixty one patients in the D&C group and 131 in the HsR
group wanted to be pregnant again. There were, respectively,
42 and 72 patients lost to follow-up (LTFU) in the HsR
and D&C groups. There is no difference in the meantime of
conception between the two groups. As previously reported,
the use of assisted reproductive therapy is considerably higher
in HsR than D&C group making the first one a “hypofertile”
population. Hence this fact and the important rate of lost-
to-follow-up, a multivariate Cox regression model, adjusted to
the IVF factor, was performed and limited at 6 months to
reduce the influence of the LTFU patients. The difference in
TABLE 3 | Reproductive outcomes at 6 months after HsR or D&C for missed
abortion.
HsR (n = 185) D&C (n = 173) p-value
Lost to follow-up at 6 months 42 72 <0.001
Patients with desire of pregnancy 131 161 <0.001
Overall pregnancy 52/131 (39.7%) 43/161 (26.7%) 0.018
Mean time to conception (months) 4.73 4.77 0.35
pregnancy rate is significantly greater in the HsR group than in
the D&C group with, respectively, 52/131 (39.7%) and 43/161
(26.7%) pregnancies at 6 months (p = 0.018). The hazard
ratio at 6 months is 0.69 [0.49–0.96] (p = 0.026). With all
the limitations of a retrospective analysis and the very different
population in the two groups, our result seems to show an
advantage in reproductive outcomes of HsR compared to D&C
in a hypofertile group of patient who require IVF to obtain
their pregnancies.
DISCUSSION
Residual trophoblastic tissue is a common complication of
miscarriage. When a surgical management is needed, RPOC
are usually treated by D&C. A significant complication of
these interventions are IUAs which occur in ∼15% for a
single curettage (8) and 40% for repeated curettage (13)
and compromise fertility. Since miscarriage usually occurs
in patients desiring pregnancy, fertility is a key point in
the management of miscarriage. As alternatives to blind
D&C, ultrasound-guided curettage and hysteroscopic resection
of RPOC have been developed in order to visualize the
intervention in an attempt to minimize unnecessary trauma
to the endometrium. There are 3 studies comparing D&C to
HsR showing fewer IUAs (9), better pregnancy rate (9) and
quicker post-operative pregnancy (9–11) in the HsR group
for patients with post-operative or post-partum trophoblastic
remnants. To our knowledge, this study is the first to explore
HsR in primary surgical management of missed abortion and
to evaluate reproductive outcomes in comparison with classical
D&C technique.
We found similar rates of intra- and post-operative
complications and there were no complication due
to glycine resorption for which surgeons are wary of
haemodilution (14). HsR seems to be as safe as D&C in
the treatment of missed abortion. Furthermore, the HsR
allowed the diagnosis of intrauterine anomalies in 5.4% of
patients. Those were sometimes treated during the same
intervention but were mostly investigated at distance of the
miscarriage. This is particularly interesting knowing that
intrauterine anomalies such as polyps, septum and fibroid can
favor miscarriage.
Regarding the reproductive outcomes, sub analysis of our data
(trying to minimize the differences between the two groups and
reducing the impact of the importance of the LTFU) showed
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a hazard ratio of pregnancy at 6 month of 0.69 for the D&C
compared to HsR. This technique could be a good choice for a
hypofertile population needing IVF to obtain their pregnancy.
It also rejoin the conclusion of Ozgur et al. in their study (15)
which shows a six months recovery time needed to restore the
reproductive capacity after D&C for patient followed in IVF.
The retrospective design, the number of patients lost-to-
follow-up and the heterogeneity between the two groups are
clearly limiting the strength of our conclusions but could,
as all the research studies, be the first step to build more
qualitative studies to evaluate the best surgical management for
missed abortions.
In conclusion, the present study shows that hysteroscopic
resection is feasible and as safe as D&C for the management of
missed abortion. It seems to be associated with better pregnancy
rate at 6 months in a hypofertile population requiring IVF.
This exploratory analysis of HsR for the management of missed
abortions is very encouraging and could be a step to design a
prospective randomized trial over the surgical management of
missed abortions.
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